Novacyt to collaborate to validate HPV testing with NOVAprep® technology

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has announced it will validate the NOVAprep® liquid-based cytology platform with Abbott’s RealTime High Risk HPV (Human papillomavirus) assay. Download press release

Visit Page

Novacyt launch next generation NOVAprep® instrumentation in China

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces an update to its launch of NOVAprep® in China through its partnership with Leica Biosystems. Download press release

Visit Page

Novacyt extends user base into Middle East and secures new patents

Novacyt (Mmemo: ALNOV – FR0010397232) announces the installation of NovaPrep in Kuwait. Download press release

Visit Page